Your browser doesn't support javascript.
loading
Multiple electrode aggregometry for the assessment of acquired platelet dysfunctions during extracorporeal circulation.
Mutlak, Haitham; Reyher, Christian; Meybohm, Patrick; Papadopoulos, Nestoras; Hanke, Alexander Alfons; Zacharowski, Kai; Weber, Christian Friedrich.
Afiliação
  • Mutlak H; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt, Germany.
  • Reyher C; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt, Germany.
  • Meybohm P; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt, Germany.
  • Papadopoulos N; Department of Thoracic and Cardiovascular Surgery, University Hospital Frankfurt, Frankfurt, Germany.
  • Hanke AA; Department of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany.
  • Zacharowski K; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt, Germany.
  • Weber CF; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt, Germany.
Thorac Cardiovasc Surg ; 63(1): 21-7, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25083831
ABSTRACT

BACKGROUND:

There have been many reports on how the usage of extracorporeal circulation (ECC) is independently associated with the induction of platelet dysfunctions. The aim of the present investigation was to study the capability of the multiple electrode aggregometry (MEA) using the Multiplate (Roche AG, Grenzach, Germany) device to reflect the extent of ECC-associated platelet dysfunctions. PATIENTS AND

METHODS:

The study population consisted of patients who were treated with either hypothermic (cardiopulmonary bypass [CPB]) or normothermic (extracorporeal membrane oxygenation) ECC. Hemostatic analyses included conventional laboratory coagulation tests and aggregometric measures following stimulation with different agonists using MEA. The area under the aggregation curve in the ADPtest (ex vivo adenosine diphosphate induced platelet aggregation) of the MEA was defined as the primary end point. The analyses were performed before the usage of ECC (baseline) and 90 minutes (T1), 120 minutes (T2), 150 minutes (T3), and 180 minutes (T4) after the usage of ECC. In the hypothermic ECC group, additional hemostatic analyses were performed after the patient's postoperative admission to the intensive care unit (T5). Periprocedural data and results of other hemostatic testing were defined as secondary end points.

RESULTS:

A total of n = 40 patients were assessed for eligibility and n = 25 patients were finally enrolled into the study (hypothermic ECC group n = 20; normothermic ECC group n = 5). The extent of ADP-induced platelet aggregation decreased significantly between baseline and consecutive measuring points during hypothermic ECC and remained unchanged between T4 and T5. In the normothermic ECC group, ADP-induced aggregability was significantly lower at T1 compared with baseline and remained unchanged from T1 onward.

CONCLUSION:

Data from the present study indicate that ex vivo ADP-induced platelet aggregation in MEA reflects the time-dependent extent of ECC-induced platelet dysfunction.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes de Função Plaquetária / Transtornos Plaquetários / Circulação Extracorpórea Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes de Função Plaquetária / Transtornos Plaquetários / Circulação Extracorpórea Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article